BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tamura T, Inagawa S, Hisakura K, Enomoto T, Ohkohchi N. Evaluation of serum high-density lipoprotein cholesterol levels as a prognostic factor in gastric cancer patients. J Gastroenterol Hepatol 2012;27:1635-40. [PMID: 22647147 DOI: 10.1111/j.1440-1746.2012.07189.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Akinyemiju T, Sakhuja S, Waterbor J, Pisu M, Altekruse SF. Racial/ethnic disparities in de novo metastases sites and survival outcomes for patients with primary breast, colorectal, and prostate cancer. Cancer Med 2018;7:1183-93. [PMID: 29479835 DOI: 10.1002/cam4.1322] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
2 Wang Y, Sun XQ, Lin HC, Wang DS, Wang ZQ, Shao Q, Wang FH, Yan SM, Liang JY, Zeng ZL, Ju HQ, Xu RH, Li YH. Correlation between immune signature and high-density lipoprotein cholesterol level in stage II/III colorectal cancer. Cancer Med 2019;8:1209-17. [PMID: 30729718 DOI: 10.1002/cam4.1987] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
3 Mayengbam SS, Singh A, Pillai AD, Bhat MK. Influence of cholesterol on cancer progression and therapy. Transl Oncol 2021;14:101043. [PMID: 33751965 DOI: 10.1016/j.tranon.2021.101043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Luo XL, Zhong GZ, Hu LY, Chen J, Liang Y, Chen QY, Liu Q, Rao HL, Chen KL, Cai QQ. Serum apolipoprotein A-I is a novel prognostic indicator for non-metastatic nasopharyngeal carcinoma. Oncotarget 2015;6:44037-48. [PMID: 26503474 DOI: 10.18632/oncotarget.5823] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
5 Cheng T, Dai X, Zhou DL, Lv Y, Miao LY. Correlation of apolipoprotein A-I kinetics with survival and response to first-line platinum-based chemotherapy in advanced non-small cell lung cancer. Med Oncol 2015;32:407. [PMID: 25465061 DOI: 10.1007/s12032-014-0407-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wei XL, Luo TQ, Li JN, Xue ZC, Wang Y, Zhang Y, Chen YB, Peng C. Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes in Gastric Cancer. Front Mol Biosci 2021;8:691143. [PMID: 34277706 DOI: 10.3389/fmolb.2021.691143] [Reference Citation Analysis]
7 Savolainen MJ. Epidemiology: Disease Associations and Modulators of HDL-Related Biomarkers. In: von Eckardstein A, Kardassis D, editors. High Density Lipoproteins. Cham: Springer International Publishing; 2015. pp. 259-83. [DOI: 10.1007/978-3-319-09665-0_7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
8 Zou Y, Wu L, Yang Y, Ding Z, Huang J, Li P, Zhu C, Yuan Y. Serum lipid levels correlate to the progression of gastric cancer with neuroendocrine immunophenotypes: A multicenter retrospective study. Transl Oncol 2021;14:100925. [PMID: 33137542 DOI: 10.1016/j.tranon.2020.100925] [Reference Citation Analysis]
9 Wei XL, Qiu MZ, Lin HX, Zhang Y, Liu JX, Yu HM, Liang WP, Jin Y, Ren C, He MM, Chen WW, Luo HY, Wang ZQ, Zhang DS, Wang FH, Li YH, Xu RH. Patients with old age or proximal tumors benefit from metabolic syndrome in early stage gastric cancer. PLoS One 2014;9:e89965. [PMID: 24599168 DOI: 10.1371/journal.pone.0089965] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
10 Wang L, Chi P, Chen H, Xiang J, Xia Z, Zhang Y. Low level of high-density lipoprotein cholesterol correlates with poor prognosis in extranodal natural killer/T cell lymphoma. Tumor Biol 2014;35:2141-9. [DOI: 10.1007/s13277-013-1284-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
11 Mo ZC, Ren K, Liu X, Tang ZL, Yi GH. A high-density lipoprotein-mediated drug delivery system. Adv Drug Deliv Rev 2016;106:132-47. [PMID: 27208399 DOI: 10.1016/j.addr.2016.04.030] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 7.5] [Reference Citation Analysis]
12 Javeed R, Jabeen F, Saeed H, Najam-ul-haq M. Advance Workflow in Lipoproteomics via Polymeric Ion Exchanger. Anal Chem 2015;87:3505-12. [DOI: 10.1021/acs.analchem.5b00058] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
13 Lee Y, Joo J, Lee YJ, Lee EK, Park S, Kim TS, Lee SH, Kim SY, Wie GA, Park M, Kim MJ, Lee JS, Han JY. Randomized phase II study of platinum-based chemotherapy plus controlled diet with or without metformin in patients with advanced non-small cell lung cancer. Lung Cancer 2021;151:8-15. [PMID: 33278671 DOI: 10.1016/j.lungcan.2020.11.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Bai L, Yan XL, Lu YX, Meng Q, Rong YM, Ye LF, Pan ZZ, Xing BC, Wang DS. Circulating Lipid- and Inflammation-Based Risk (CLIR) Score: A Promising New Model for Predicting Outcomes in Complete Colorectal Liver Metastases Resection. Ann Surg Oncol 2022. [PMID: 35254582 DOI: 10.1245/s10434-021-11234-0] [Reference Citation Analysis]
15 Hao B, Peng X, Bi B, Yu M, Sang C, Chen Z. Preoperative serum high-density lipoprotein cholesterol as a predictor of poor survival in patients with clear cell renal cell cancer. Int J Biol Markers 2019;34:168-75. [DOI: 10.1177/1724600819831404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Hao B, Bi B, Sang C, Yu M, Di D, Luo G, Zhang X. Systematic Review and Meta-Analysis of the Prognostic Value of Serum High-Density Lipoprotein Cholesterol Levels for Solid Tumors. Nutrition and Cancer 2019;71:547-56. [DOI: 10.1080/01635581.2019.1577983] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
17 Li YT, Zhou XS, Han XM, Tian J, Qin Y, Zhang T, Liu JL. Pretreatment serum albumin-to-alkaline phosphatase ratio is an independent prognosticator of survival in patients with metastatic gastric cancer. World J Gastrointest Oncol 2022; 14(5): 1002-1013 [DOI: 10.4251/wjgo.v14.i5.1002] [Reference Citation Analysis]
18 Zhu PW, Gong YX, Min YL, Lin Q, Li B, Shi WQ, Yuan Q, Ye L, Shao Y. The predictive value of high-density lipoprotein for ocular metastases in colorectal cancer patients. Cancer Manag Res. 2019;11:3511-3519. [PMID: 31118776 DOI: 10.2147/cmar.s194637] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
19 Wu YT, Luo QQ, Li X, Arshad B, Xu Z, Ran L, Zhao CX, Wu H, Shi YL, Chen HR, Li H, Li HY, Wu KN, Kong LQ. Clinical study on the prevalence and comparative analysis of metabolic syndrome and its components among Chinese breast cancer women and control population. J Cancer 2018;9:548-55. [PMID: 29483960 DOI: 10.7150/jca.22968] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
20 Dai D, Chen B, Wang B, Tang H, Li X, Zhao Z, Li X, Xie X, Wei W. Pretreatment TG/HDL-C Ratio Is Superior to Triacylglycerol Level as an Independent Prognostic Factor for the Survival of Triple Negative Breast Cancer Patients. J Cancer 2016;7:1747-54. [PMID: 27698913 DOI: 10.7150/jca.15776] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
21 Munir R, Usman H, Hasnain S, Smans K, Kalbacher H, Zaidi N. Atypical plasma lipid profile in cancer patients: cause or consequence? Biochimie 2014;102:9-18. [PMID: 24704108 DOI: 10.1016/j.biochi.2014.03.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
22 Rosiello G, Palumbo C, Deuker M, Stolzenbach LF, Martin T, Tian Z, Gallina A, Montorsi F, Black P, Kassouf W, Shariat SF, Saad F, Briganti A, Karakiewicz PI. Racial differences in the distribution of bladder cancer metastases: a population-based analysis. Cent European J Urol 2020;73:407-15. [PMID: 33552564 DOI: 10.5173/ceju.2020.0269] [Reference Citation Analysis]
23 Wang X, Wu C, Yuan B, Wang D, Liu H, Feng H, Sun S. Low scavenger receptor class B type I expression is associated with gastric adenocarcinoma tumor aggressiveness. Oncol Lett 2018;15:4604-10. [PMID: 29541232 DOI: 10.3892/ol.2018.7889] [Reference Citation Analysis]
24 Zhang Y, Zhang X. Controlling nutritional status score, a promising prognostic marker in patients with gastrointestinal cancers after surgery: A systematic review and meta-analysis. International Journal of Surgery 2018;55:39-45. [DOI: 10.1016/j.ijsu.2018.05.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
25 Yang S, Zhao K, Ding X, Jiang H, Lu H. Prognostic Significance of Hematological Markers for Patients with Nasopharyngeal Carcinoma: A Meta-analysis. J Cancer 2019;10:2568-77. [PMID: 31258763 DOI: 10.7150/jca.26770] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
26 Ha TK, Seo YK, Kang BK, Shin J, Ha E. Cardiovascular Risk Factors in Gastric Cancer Patients Decrease 1 Year After Gastrectomy. OBES SURG 2016;26:2340-7. [DOI: 10.1007/s11695-016-2085-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
27 Chang WC, Huang SF, Lee YM, Lai HC, Cheng BH, Cheng WC, Ho JY, Jeng LB, Ma WL. Cholesterol import and steroidogenesis are biosignatures for gastric cancer patient survival. Oncotarget 2017;8:692-704. [PMID: 27893427 DOI: 10.18632/oncotarget.13524] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
28 Luo F, Zeng KM, Cao JX, Zhou T, Lin SX, Ma WJ, Yang YP, Zhang ZH, Lu FT, Huang Y, Zhao HY, Zhang L. Predictive value of a reduction in the level of high-density lipoprotein-cholesterol in patients with non-small-cell lung cancer undergoing radical resection and adjuvant chemotherapy: a retrospective observational study. Lipids Health Dis 2021;20:109. [PMID: 34544437 DOI: 10.1186/s12944-021-01538-1] [Reference Citation Analysis]
29 Akinyemiju T, Moore JX, Pisu M, Judd SE, Goodman M, Shikany JM, Howard VJ, Safford M, Gilchrist SC. A Prospective Study of Obesity, Metabolic Health, and Cancer Mortality. Obesity (Silver Spring) 2018;26:193-201. [PMID: 29178569 DOI: 10.1002/oby.22067] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
30 Shi H, Huang H, Pu J, Shi D, Ning Y, Dong Y, Han Y, Zarogoulidis P, Bai C. Decreased pretherapy serum apolipoprotein A-I is associated with extent of metastasis and poor prognosis of non-small-cell lung cancer. Onco Targets Ther 2018;11:6995-7003. [PMID: 30410356 DOI: 10.2147/OTT.S170227] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
31 Cantiello F, Cicione A, Autorino R, Salonia A, Briganti A, Ferro M, De Domenico R, Perdonà S, Damiano R. Visceral obesity predicts adverse pathological features in urothelial bladder cancer patients undergoing radical cystectomy: a retrospective cohort study. World J Urol 2014;32:559-64. [PMID: 23942944 DOI: 10.1007/s00345-013-1147-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
32 Pih GY, Gong EJ, Choi JY, Kim MJ, Ahn JY, Choe J, Bae SE, Chang HS, Na HK, Lee JH, Jung KW, Kim DH, Choi KD, Song HJ, Lee GH, Jung HY. Associations of Serum Lipid Level with Gastric Cancer Risk, Pathology, and Prognosis. Cancer Res Treat 2021;53:445-56. [PMID: 33253515 DOI: 10.4143/crt.2020.599] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Wang Y, Wang ZQ, Wang FH, Lei XF, Yan SM, Wang DS, Zhang F, Xu RH, Wang LY, Li YH. Predictive value of chemotherapy-related high-density lipoprotein cholesterol (HDL) elevation in patients with colorectal cancer receiving adjuvant chemotherapy: an exploratory analysis of 851 cases. Oncotarget 2016;7:57290-300. [PMID: 27344180 DOI: 10.18632/oncotarget.10145] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
34 Jeon CH, Park KB, Jung YJ, Seo HS, Park CH, Song KY, Lee HH. Modified controlling nutritional status score: A refined prognostic indicator depending on the stage of gastric cancer. Surg Oncol 2020;34:261-9. [PMID: 32891340 DOI: 10.1016/j.suronc.2020.05.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Zhou T, Zhan J, Fang W, Zhao Y, Yang Y, Hou X, Zhang Z, He X, Zhang Y, Huang Y, Zhang L. Serum low-density lipoprotein and low-density lipoprotein expression level at diagnosis are favorable prognostic factors in patients with small-cell lung cancer (SCLC). BMC Cancer 2017;17:269. [PMID: 28410578 DOI: 10.1186/s12885-017-3239-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
36 Jiang R, Yang ZH, Luo DH, Guo L, Sun R, Chen QY, Huang PY, Qiu F, Zou X, Cao KJ, Mai HQ, Guo X, Qian CN, Hong MH, Chen MY. Elevated apolipoprotein A-I levels are associated with favorable prognosis in metastatic nasopharyngeal carcinoma. Med Oncol 2014;31:80. [PMID: 25023050 DOI: 10.1007/s12032-014-0080-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]